-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, DlU2YbXWRGyZ3U8CkArZzeJhubbnbaQk+qQrtDHiClYguM4GmFYshshjZU979okt k39op4cw6TnMhatWqv2ziw== 0001144204-07-061468.txt : 20071114 0001144204-07-061468.hdr.sgml : 20071114 20071114161044 ACCESSION NUMBER: 0001144204-07-061468 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070930 FILED AS OF DATE: 20071114 DATE AS OF CHANGE: 20071114 EFFECTIVENESS DATE: 20071114 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BAKER BROS ADVISORS LLC CENTRAL INDEX KEY: 0001263508 IRS NUMBER: 134093645 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-10519 FILM NUMBER: 071244917 BUSINESS ADDRESS: STREET 1: 667 MADISON AVENUE STREET 2: 17TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10021 BUSINESS PHONE: 2125212418 13F-HR 1 v093636_13fhr.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 13F FORM 13F COVER PAGE Report for the Calendar Year or Quarter Ended: September 30, 2007 Check here if Amendment [ ]; Amendment Number: _____ This Amendment (Check only one.): [ ] is a restatement. [ ] adds new holdings entries. Institutional Investment Manager Filing this Report: Name: Baker Bros. Advisors, LLC -------------------------------------------- Address: 667 Madison Avenue, 17th Floor -------------------------------------------- New York, NY 10065-8029 -------------------------------------------- Form 13F File Number: 28-10519 The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form. Person Signing this Report on Behalf of Reporting Manager: Name: Leo Kirby -------------------------------------------- Title: Chief Financial Officer -------------------------------------------- Phone: 212-339-5633 -------------------------------------------- Signature, Place, and Date of Signing: /s/ Leo Kirby New York, N.Y. November 14, 2007 - -------------------------- --------------------------- ---------------------- [Signature] [City, State] [Date] Report Type (Check only one.): [X] 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.) [_] 13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).) [_] 13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).) List of Other Managers Reporting for this Manager: None FORM 13F SUMMARY PAGE Report Summary: Number of Other Included Managers: 0 ----------- Form 13F Information Table Entry Total: 91 ----------- Form 13F Information Table Entry Value: 1,145,423 ----------- (thousands) List of Other Included Managers: None Baker Brothers Form 13F 9-30-07
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8 VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY Name of Issuer CUSIP (x1000) PRN AMT PRN CALL DISCRETION MANAGERS SOLE SHARED NONE - ---------------------------- ------- ------- ------- --- ---- ---------- -------- ---- ------ ---- Acadia Pharmaceuticals Inc. COM 004225108 31,584 2,098,595 SH SOLE 2,098,595 Acorda Therapeutics COM 00484M106 21,054 1,147,390 SH SOLE 1,147,390 Adolor Corp. COM 00724X102 872 254,921 SH SOLE 254,921 Alkermes COM 01642T108 3,598 195,557 SH SOLE 195,557 Allos Therapeutics Inc. COM 019777101 41,522 8,741,480 SH SOLE 8,741,480 Alsius Corp. COM 021211107 396 64,850 SH SOLE 64,850 Altus Pharmaceuticals Inc. COM 02216N105 425 40,477 SH SOLE 40,477 Amicus Therapeutics COM 03152W109 12,711 760,680 SH SOLE 760,680 Amylin Pharmaceuticals Inc. COM 032346108 44,590 891,794 SH SOLE 891,794 Anesiva Inc. COM 21872P501 8,093 1,409,854 SH SOLE 1,409,854 AP Pharma COM 00202J203 3,106 1,515,152 SH SOLE 1,515,152 Aradigm Corp. COM 038505301 133 100,000 SH SOLE 100,000 Arena Pharmaceuticals Inc. COM 040047102 306 27,930 SH SOLE 27,930 Array Biopharma Inc. COM 04269X105 2,941 261,928 SH SOLE 261,928 Atherogenics Inc. COM 047439104 42 25,357 SH SOLE 25,357 Autoimmune Inc. COM 052776101 35 26,100 SH SOLE 26,100 Auxilium COM 05334D107 34,672 1,644,766 SH SOLE 1,644,766 Biocryst Pharmaceuticals Inc. COM 09058V103 42,731 5,918,411 SH SOLE 5,918,411 BioEnvision COM 09059N100 271 51,394 SH SOLE 51,394 Biomarin Pharmaceutical Inc. COM 09061G101 524 21,053 SH SOLE 21,053 Cerus Corp. COM 157085101 2,036 233,167 SH SOLE 233,167 Chelsea Therapeutics COM 163428105 4,578 684,309 SH SOLE 684,309 Coley Pharmaceutical Group Inc. COM 19388P106 1,800 573,098 SH SOLE 573,098 Critical Therapeutics Inc. COM 22674T105 2,110 1,146,913 SH SOLE 1,146,913 Curis Inc. COM 231269101 26 26,800 SH SOLE 26,800 Cyclacel Pharmaceuticals COM 23254L108 1,523 273,386 SH SOLE 273,386 Cyclacel Pharmaceuticals Pfd. Conv. Ex 6% PFD CONV EX 23254L207 526 95,500 SH SOLE 95,500 Cytokinetics Inc. COM 23282W100 8,765 1,711,864 SH SOLE 1,711,864 Emergent Biosolutions COM 29089Q105 2,714 305,593 SH SOLE 305,593 Epix Pharmaceuticals COM 26881Q309 369 90,783 SH SOLE 90,783 Exelisis COM 30161Q104 1,871 176,657 SH SOLE 176,657 Genelabs Technologies Inc. COM 368706206 1,435 755,179 SH SOLE 755,179 Genomic Health Inc. COM 37244C101 91,980 4,793,090 SH SOLE 4,793,090 Halozyme Therapeutics Inc. COM 40637H109 7,690 884,933 SH SOLE 884,933 Icagen Inc. COM 45104P104 151 75,468 SH SOLE 75,468 Idera Pharmaceuticals Inc. COM 45168K108 20,000 2,272,725 SH SOLE 2,272,725 Immunogen Inc. COM 45253H101 1,326 285,100 SH SOLE 285,100 Immunomedics, Inc. COM 452907108 286 125,000 SH SOLE 125,000 Incyte Corp. COM 45337C102 27,518 3,848,626 SH SOLE 3,848,626 Indevus Pharmaceuticals COM 454072109 4,842 700,794 SH SOLE 700,794 Infinity Pharmaceuticals Inc. COM 45665G303 776 85,651 SH SOLE 85,651 Intermune Inc. COM 45884X103 27,074 1,415,285 SH SOLE 1,415,285 Isis Pharmaceuticals Inc. COM 464330109 282 18,859 SH SOLE 18,859 Kosan COM 50064W107 11,626 2,320,524 SH SOLE 2,320,524 Ligand Pharmaceuticals Inc. CL B 53220K207 204 38,224 SH SOLE 38,224 Medarex Inc. COM 583916101 5,776 404,191 SH SOLE 404,191 Memory Pharma COM 58606R403 363 153,006 SH SOLE 153,006 Metabasis Therapeutics Inc. COM 59101M105 6,817 2,334,466 SH SOLE 2,334,466 Micromet COM 59509C105 4,398 2,221,614 SH SOLE 2,221,614 Myriad Genetics Inc. COM 62855J104 31,702 607,902 SH SOLE 607,902 Neopharm Inc. COM 640919106 54 54,643 SH SOLE 54,643 Neose Technologies Inc. COM 640522108 3,442 2,235,590 SH SOLE 2,235,590 Neurogen Corp. COM 64124E106 22,853 5,147,078 SH SOLE 5,147,078 Novo-Nordisk COM 670100205 25,422 210,028 SH SOLE 210,028 Onyx Inc. COM 683399109 5,468 125,650 SH SOLE 125,650 Optimer Pharmaceuticals COM 68401H104 10,367 1,247,500 SH SOLE 1,247,500 OSI Pharmaceuticals COM 671040103 7,608 223,826 SH SOLE 223,826 Pharmacyclics Inc. COM 716933106 744 323,598 SH SOLE 323,598 Pharmasset Inc. COM 71715N106 2,165 178,056 SH SOLE 178,056 Pharmion Corp. COM 71715B409 112,702 2,442,605 SH SOLE 2,442,605 Poniard Pharmaceuticals Inc. COM 732449301 214 37,755 SH SOLE 37,755 Pozen Inc. COM 73941U102 3,570 322,753 SH SOLE 322,753 Salix Pharmaceuticals, Inc. COM 795435106 4,346 349,906 SH SOLE 349,906 Seattle Genetics Inc. COM 812578102 52,970 4,712,589 SH SOLE 4,712,589 Siga Technologies Inc. COM 826917106 3,822 955,488 SH SOLE 955,488 Sirtris Pharmaceuticals Inc. COM 82968A105 407 23,843 SH SOLE 23,843 Spectrum Pharmaceuticals Inc. COM 84763A108 3,348 793,257 SH SOLE 793,257 Sunesis Pharmaceuticals Inc. COM 867328502 3,042 1,317,039 SH SOLE 1,317,039 Supergen COM 868059106 5,183 1,194,249 SH SOLE 1,194,249 Symyx Technologies, Inc. COM 87155S108 2,630 302,621 SH SOLE 302,621 Tapestry Pharmaceuticals Inc. COM 876031204 3,020 2,000,000 SH SOLE 2,000,000 Targacept COM 87611R306 1,240 137,950 SH SOLE 137,950 Theravance Inc. COM 88338T104 10,720 410,869 SH SOLE 410,869 Threshold Pharma COM 885807107 2,015 2,263,600 SH SOLE 2,263,600 Torreypines Therapeutics COM 89235K105 1,237 204,465 SH SOLE 204,465 Trimeris Inc. COM 896263100 26,928 3,461,175 SH SOLE 3,461,175 Vertex Pharmaceuticals Inc. COM 92532F100 55,048 1,433,161 SH SOLE 1,433,161 Viacell COM 92554J105 47 10,024 SH SOLE 10,024 Via Pharmaceuticals COM 92554T103 368 102,881 SH SOLE 102,881 Vion Pharm COM 927624AA4 114 148,118 SH SOLE 148,118 Viropharma Inc. COM 928241108 53,795 6,044,413 SH SOLE 6,044,413 Xenoport Inc. COM 98411C100 46,482 987,918 SH SOLE 987,918 Alexion Pharmaceuticals Notes 1.375% 2/01/2012 CONV BONDS 015351AF6 17,700 8,300,000 PRN SOLE 8,300,000 Amylin Pharmaceuticals Notes 2.5% 4/15/11 CONV BONDS 032346AD0 10,929 7,000,000 PRN SOLE 7,000,000 Biomarin Pharmaceuticals Notes 1.875% 4/23/2017 CONV BONDS 09061GAD3 16,530 12,000,000 PRN SOLE 12,000,000 Biomarin Pharmaceuticals Notes 2.5% 3/29/2013 CONV BONDS 09061GAC5 30,244 18,569,000 PRN SOLE 18,569,000 Incyte Genomics Notes 3.5% 2/15/2011 CONV BONDS 45337CAE2 17,359 18,972,000 PRN SOLE 18,972,000 Intermune Inc Notes .25% 3/01/2011 CONV BONDS 45884XAC7 9,563 8,500,000 PRN SOLE 8,500,000 Medarex Inc Notes 2.25% 5/15/2011 CONV BONDS 583916AG6 16,907 13,472,000 PRN SOLE 13,472,000 Viropharma Inc. Notes 2.0% 3/15/2017 CONV BONDS 928241AH1 34,650 45,000,000 PRN SOLE 45,000,000
-----END PRIVACY-ENHANCED MESSAGE-----